How does Arg16Gly polymorphism affect pulmonary function and treatment response in COPD patients?
N. Slepchenko (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine), K. Dmytriiev (Vinnytsya, Ukraine), Y. Smereka (Vinnytsya, Ukraine), D. Dmytriiev (Vinnytsya, Ukraine)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3622
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Slepchenko (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine), K. Dmytriiev (Vinnytsya, Ukraine), Y. Smereka (Vinnytsya, Ukraine), D. Dmytriiev (Vinnytsya, Ukraine). How does Arg16Gly polymorphism affect pulmonary function and treatment response in COPD patients?. 3622
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|